4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-031113
Options or other derivatives
- Interim CEO & General Counsel acquired 593,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Vogt Frederick G · Interim CEO & General Counsel
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-01 | Grant or award : show line 1 in the form Restricted Stock Units | +500,000 | 500,000 | D |
| 2024-03-01 | Grant or award : show line 2 in the form Restricted Stock Units | +93,750 | 93,750 | D |
Loading xslF345X05/tm248017-9_4seq1.xml…